Drug Research
FDF China to be held in June to boost Chinese pharmaceutical enterprises to “go global” and promote the innovation and development of industry
FDF China, collocated with CPhI China, will be held from June 22-24, 2020 at Shanghai New International Expo Centre (SNIEC). More and more formulation enterprises need to implement strategic layout to step up cooperation in innovation and facilitate the...
Drug Research
Discover the Latest Information and Seize Market Opportunities in the Annual Event of the CRO & CMO Industry
As the pharmaceutical market demands in China continue to grow, China’s pharmaceutical policies become gradually clear, which provides broad space for the development of pharmaceutical enterprises. The CRO & CMO industry, an important part of the R&D industry chain...
Drug Research
IONTAS and Adaptate Biotherapeutics collaborate to identify optimised antibodies for novel cancer targets
IONTAS, a leader in the discovery and optimisation of fully human antibodies, announced it has entered into a collaboration agreement with Adaptate Biotherapeutics, developers of antibody-based therapeutics for modulation of gamma delta T-cells.
The agreement is to generate and optimise...
Drug Research
BioMotiv and Atomwise Sign AI Partnership to Transform Therapeutic Development
BioMotiv, a mission-driven pharma company part of The Harrington Project for discovery and development, and Atomwise, the leader in using artificial intelligence (AI) for small molecule discovery, announced a strategic collaboration to co-develop therapies. The organizations will form co-owned,...
Drug Research
Astellas Announces Construction of New Manufacturing Facility for Active Pharmaceutical Ingredient of Prograf
The new manufacturing facility is designed to have advanced features based on the efficiency of the existing facilities and requires approximately JPY10bn ($90m) in construction costs
Japanese pharmaceutical firm Astellas has unveiled plans to construct the Third Fermentation Building as...
Drug Research
CytoviaTherapeutics and the University of California enter into a partnership to develop precision gene-edited CAR-NK celltherapy
CytoviaTherapeutics,a biopharmaceutical company, and the University of California,San Francisco(UCSF) announced that they have entered a 3-year research partnership to develop novel precision gene editing to improve the performance, safety and persistence of Natural Killer(NK) cells and Chimeric Antigen Receptor(CAR)-NK...
Drug Research
Boehringer Ingelheim Partners with Enleofen to Develop First-in-Class Anti-IL-11 Therapies for a Range of Fibrotic Diseases
Boehringer Ingelheim and Enleofen Bio Pte. Ltd. (Enleofen) announced the acquisition of worldwide exclusive rights to Enleofen’s preclinical interleukin-11 (IL-11) platform by Boehringer Ingelheim to develop first-in-class therapies across a broad range of fibro-inflammatory diseases.
The new partnership combines Boehringer...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read